Clinical application of high-throughput genomic technologies for treatment selection in breast cancer

Large-scale collaborative initiatives using next-generation DNA sequencing and other high-throughput technologies have begun to characterize the genomic landscape of breast cancer. These landmark studies have identified infrequent driver mutations that are potential targets for therapeutic intervent...

Descripción completa

Detalles Bibliográficos
Autores principales: Hansen, Aaron R, Bedard, Philippe L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979162/
https://www.ncbi.nlm.nih.gov/pubmed/24135425
http://dx.doi.org/10.1186/bcr3558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979162/
https://www.ncbi.nlm.nih.gov/pubmed/24135425
http://dx.doi.org/10.1186/bcr3558

Ejemplares similares